Cargando…

EMDIA Case Series—Effective Medication Therapy Management (MTM) for Diabetes Type 2 Patients—A Proof of Concept Study

Background: A 2016 meta-analysis of pharmaceutical care for patients with diabetes mellitus showed that the following four components were most effective: (a) individual goal setting, (b) sending feedback to the physician, (c) reviewing the medication, and (d) reviewing blood glucose measurements. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Deters, Maira Anna, Obarcanin, Emina, Schwender, Holger, Läer, Stephanie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396324/
https://www.ncbi.nlm.nih.gov/pubmed/34449695
http://dx.doi.org/10.3390/pharmacy9030137
_version_ 1783744347558117376
author Deters, Maira Anna
Obarcanin, Emina
Schwender, Holger
Läer, Stephanie
author_facet Deters, Maira Anna
Obarcanin, Emina
Schwender, Holger
Läer, Stephanie
author_sort Deters, Maira Anna
collection PubMed
description Background: A 2016 meta-analysis of pharmaceutical care for patients with diabetes mellitus showed that the following four components were most effective: (a) individual goal setting, (b) sending feedback to the physician, (c) reviewing the medication, and (d) reviewing blood glucose measurements. Methods: To formulate a hypothesis regarding the effect of these four pharmaceutical care components on glycemic control in patients with diabetes mellitus and the feasibility of these components in practice. Ten patients with type 2 diabetes were included in the case series and received medication therapy management over four months. Results: The four care components were feasible in everyday practice and could be implemented within one patient visit. The average visits were 49 and 28 min at the beginning and end of the study, respectively. The glycated hemoglobin values did not change over the study period, though the fasting blood glucose decreased from 142 to 120 mg/dl, and the number of unsolved drug-related problems decreased from 6.9 to 1.9 per patient by the study end. Conclusions: This case series supports the hypothesis that community pharmacists can implement structured pharmaceutical care in everyday pharmacy practice for patients with type 2 diabetes mellitus.
format Online
Article
Text
id pubmed-8396324
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-83963242021-08-28 EMDIA Case Series—Effective Medication Therapy Management (MTM) for Diabetes Type 2 Patients—A Proof of Concept Study Deters, Maira Anna Obarcanin, Emina Schwender, Holger Läer, Stephanie Pharmacy (Basel) Article Background: A 2016 meta-analysis of pharmaceutical care for patients with diabetes mellitus showed that the following four components were most effective: (a) individual goal setting, (b) sending feedback to the physician, (c) reviewing the medication, and (d) reviewing blood glucose measurements. Methods: To formulate a hypothesis regarding the effect of these four pharmaceutical care components on glycemic control in patients with diabetes mellitus and the feasibility of these components in practice. Ten patients with type 2 diabetes were included in the case series and received medication therapy management over four months. Results: The four care components were feasible in everyday practice and could be implemented within one patient visit. The average visits were 49 and 28 min at the beginning and end of the study, respectively. The glycated hemoglobin values did not change over the study period, though the fasting blood glucose decreased from 142 to 120 mg/dl, and the number of unsolved drug-related problems decreased from 6.9 to 1.9 per patient by the study end. Conclusions: This case series supports the hypothesis that community pharmacists can implement structured pharmaceutical care in everyday pharmacy practice for patients with type 2 diabetes mellitus. MDPI 2021-08-09 /pmc/articles/PMC8396324/ /pubmed/34449695 http://dx.doi.org/10.3390/pharmacy9030137 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Deters, Maira Anna
Obarcanin, Emina
Schwender, Holger
Läer, Stephanie
EMDIA Case Series—Effective Medication Therapy Management (MTM) for Diabetes Type 2 Patients—A Proof of Concept Study
title EMDIA Case Series—Effective Medication Therapy Management (MTM) for Diabetes Type 2 Patients—A Proof of Concept Study
title_full EMDIA Case Series—Effective Medication Therapy Management (MTM) for Diabetes Type 2 Patients—A Proof of Concept Study
title_fullStr EMDIA Case Series—Effective Medication Therapy Management (MTM) for Diabetes Type 2 Patients—A Proof of Concept Study
title_full_unstemmed EMDIA Case Series—Effective Medication Therapy Management (MTM) for Diabetes Type 2 Patients—A Proof of Concept Study
title_short EMDIA Case Series—Effective Medication Therapy Management (MTM) for Diabetes Type 2 Patients—A Proof of Concept Study
title_sort emdia case series—effective medication therapy management (mtm) for diabetes type 2 patients—a proof of concept study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396324/
https://www.ncbi.nlm.nih.gov/pubmed/34449695
http://dx.doi.org/10.3390/pharmacy9030137
work_keys_str_mv AT detersmairaanna emdiacaseserieseffectivemedicationtherapymanagementmtmfordiabetestype2patientsaproofofconceptstudy
AT obarcaninemina emdiacaseserieseffectivemedicationtherapymanagementmtmfordiabetestype2patientsaproofofconceptstudy
AT schwenderholger emdiacaseserieseffectivemedicationtherapymanagementmtmfordiabetestype2patientsaproofofconceptstudy
AT laerstephanie emdiacaseserieseffectivemedicationtherapymanagementmtmfordiabetestype2patientsaproofofconceptstudy